Ulcerative Colitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Publisher Name :
Date: 01-Nov-2016
No. of pages: 100
This report is available at upto 40% Discount. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's Report, "Ulcerative Colitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Ulcerative Colitis Report is to understand the market and pipeline status of the drugs around the Ulcerative Colitis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Ulcerative Colitis. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight's report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Scope:

- A snapshot of the global Market and Phase III therapeutics scenario for Ulcerative Colitis.

- A review of the marketed products under prescription for Ulcerative Colitis, regulatory information and marketing status.

- Coverage of global patent coverage and detailed commentaries on the US patent challenges.

- Graphical representation of investigational products for patent expiry and market exclusivities across the globe.

- Product profiles for marketed products for Ulcerative Colitis with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.

- Coverage of API Manufacturers for Ulcerative Colitis drugs in the United States, Europe and Asian Regions with location details.

- Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Ulcerative Colitis drugs.

- Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Ulcerative Colitis drugs.

- Coverage of Ulcerative Colitis Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.

- Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.

- Key discontinued Marketed products.

- Global Sales Figure to 2018.

Reasons to buy

- Evaluate the marketing status and exclusivity details of Ulcerative Colitis key products to exploit opportunities for generic drug development opportunities.

- Identify and understand important and diverse types of therapeutics under Phase III development for Ulcerative Colitis.

- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Ulcerative Colitis.

- API intelligence over marketed drugs for Ulcerative Colitis and gaining primary intelligence over active ingredients manufacturers across the globe.

- API intelligence over leading Phase III Pipeline drugs.

- Develop and design strategies by identifying the API manufacturers for Phase III Pipeline products to enhance and expand business potential and scope.

- Understanding the scope of the Phase III Drugs with nil regulatory filings.

- Understanding the chemical route of synthesis of approved drugs for Ulcerative Colitis.

- Uncovering opportunities in the rapidly growing US market.

Ulcerative Colitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Table of Contents

1. Indication Overview
2. Market Drugs Landscape
2.1 Marketed Drugs
2.2 Marketed Details of Drugs by Application Type
2.3 Marketed Details of Drugs (NDA) by Marketing Status
2.4 Marketed Details of Drugs by Patent Expiration Timeline
3. Global API Manufacturers Assessment
3.1 API Manufacturers by United States Drug Master File (US DMF) Status
3.2 API Manufacturers by US DMF Status (Drug Specific)
3.3 API Manufacturers in Europe by Country
3.4 API Manufacturers in India by State
3.5 API Manufacturers in China by Province
3.6 Marketed Details of Approved Drugs by Geography
4. Phase III Drugs Landscape
4.1 Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
4.2 API Manufacturers by US DMF Status (Drug Specific)
5. Drugs Market Data and Forecasted Sales Figure-2018
6. Marketed Drugs for Ulcerative Colitis
6.1 Drug Name
6.1.1 Drug Description
6.1.2 Global Active Pharmaceutical Manufacturers for Drug
6.1.3 Approval Status of Drug
6.1.4 Patent and Exclusivity Details for Drug
6.1.5 Company Profile and Financials
7. Phase III Drugs for Ulcerative Colitis
7.1 Drug Name
7.1.1 Drug Description
7.1.2 United States Drug Master File (DMF)
8. Discontinued Drugs for Ulcerative Colitis
9. Appendix
10. Methodology
11. Consulting Services
12. Contact Us
13. Disclaimer

List of Tables

Ulcerative Colitis Therapeutic Market, US, Marketed Drugs by Application Type, 2016
Ulcerative Colitis Therapeutic Market, US, Marketed Drugs by Marketing Status, 2016
Ulcerative Colitis Therapeutic Market, US, (Year), 2016
Ulcerative Colitis Marketed Drugs, API Manufacturers by US DMF Status, 2016
Ulcerative Colitis Marketed Drugs, US DMF Status Drug Specific (Number), 2016
Ulcerative Colitis Drugs, API Manufacturers, Europe by Country, 2016
Ulcerative Colitis Drugs, API Manufacturers, India by State, 2016
Ulcerative Colitis Drugs, API Manufacturers, China by Province, 2016
Ulcerative Colitis Drugs, API Manufacturers by Geography 2016
Ulcerative Colitis Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2016
Ulcerative Colitis Therapeutic Market, Global Sales-2018 (in million USD)
API Manufacturers for Drug, 2016
Phase III Drugs for Ulcerative Colitis, 2016
Discontinued Drugs for Ulcerative Colitis, 2016

List of Figures

Ulcerative Colitis Therapeutic Market, US, Marketed Drugs by Application Type (%), 2016
Ulcerative Colitis Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2016
Ulcerative Colitis Therapeutic Market, US, (Year), 2016
Ulcerative Colitis Marketed Drugs, API Manufacturers by US DMF Status (%), 2016
Ulcerative Colitis Marketed Drugs, US DMF Status Drug Specific (Number), 2016
Ulcerative Colitis Drugs, API Manufacturers, Europe by Country, 2016
Ulcerative Colitis Drugs, API Manufacturers, India by State, 2016
Ulcerative Colitis Drugs, API Manufacturers, China by Province, 2016
Ulcerative Colitis Drugs, API Manufacturers by Geography 2016
Ulcerative Colitis Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2016
Ulcerative Colitis Therapeutic Market, Global Sales 2018 (in million USD)
Drug, Patent/Exclusivity Expiry (Year), 2016
  • Global Luxury Apparels Market To Do Well Owing To Numerous International Brands
    The global luxury apparels market is fired by the intensifying number of fashion marques and many designers getting wide-ranging clienteles in the form of cost-effective products. The global luxury apparels market was at US$1, 8842.69 million in 2015 and is forecast to reach US$60,793.7 million by the end of 2024. This segment of luxury goods [...]
  • Global Health and Wellness Market Boosted By Organic Products and Wearables
    Healthcare has constantly been a profitable area where buyers spend belligerently. But now, with increasing disposable earnings amid the city population and ground-breaking approaches and innovative products being developed, the overall health and wellness market is estimated for a healthy prospect. The health and wellness market is presently very dynamic owing to growing alertness amongst [...]
  • Increasing New Outlets And Striking Offers To Drive Global Pizza Market
    The global pizza market is predicted to grow at a steady CAGR of about 3% by 2020. Pizza has been gaining massive acceptance globally in the last few years. Consequently, the global pizza market is anticipated to observer considerable progress in the coming years. The growing number of pizzerias is one of the major elements [...]
  • Healthy Diet Demand In Developed Economies To Boost Nutraceuticals
    As customers scuffle to keep up with the frantic lifestyles, the necessity for healthy nutrition rises owing to dearth of time to spend on laborious exercises.  Customers are shifting their attention to swift and healthy food behaviours. Increase in intake of beverages and functional food has offered makers of nutraceuticals with money-spinning prospects to benefit [...]
  • World Economic Forum Unveils Top 10 Emerging Technologies of 2016
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies of 2016. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or [...]
  • Gastritis - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 44
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastritis - Pipeline Review, H2 2016, provides an overview of the Gastritis (Gastrointestinal) pipeline landscape.Gastritis is characterized by inflammation or swelling of the lining of the stomach. Acute gastritis lasts for a short period of time while chronic gastritis lasts for a long period of time (months to years). Gastritis can be caused by medications such as ibuprofen, aspirin, naproxen on long period......
  • Peritonitis - Pipeline Review, H2 2016
    Published: 30-Nov-2016        Price: US 2000 Onwards        Pages: 48
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peritonitis - Pipeline Review, H2 2016, provides an overview of the Peritonitis (Gastrointestinal) pipeline landscape.Peritonitis is inflammation of the peritoneum. There are two types of peritonitis. Spontaneous bacterial peritonitis (SBP) is the result of an infection of the fluid in peritoneal cavity. Secondary peritonitis is usually due to an infection that has spread from digestive tract. Symptoms include......
  • Global Proglumide Market Research Report 2016
    Published: 29-Nov-2016        Price: US 2900 Onwards        Pages: 100
    Notes: Production, means the output of Proglumide Revenue, means the sales value of Proglumide This report studies Proglumide in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering - Tianyuan Pharmachemical Institute - Hubei Prosoerity Galaxy Chemical - Hubei Yikangyuan Chemical......
  • Global Anti-Peptic Ulcer Drugs Sales Market Report 2016
    Published: 29-Nov-2016        Price: US 4000 Onwards        Pages: 108
    Notes: Sales, means the sales volume of Anti-Peptic Ulcer Drugs Revenue, means the sales value of Anti-Peptic Ulcer Drugs This report studies sales (consumption) of Anti-Peptic Ulcer Drugs in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - AstraZeneca - Ask-pharm - Takeda - Yangtze Ri......
  • Irritable Bowel Syndrome - Pipeline Review, H2 2016
    Published: 16-Nov-2016        Price: US 2000 Onwards        Pages: 140
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome - Pipeline Review, H2 2016, provides an overview of the Irritable Bowel Syndrome (Gastrointestinal) pipeline landscape.Inflammatory Bowel Diseases (IBD) is a broad term that describes conditions with chronic or recurring immune response and inflammation of the gastrointestinal tract. Signs and symptoms include abdominal cramps and pain, diarrhea that may be bloody, weight loss, loss of......
  • Celiac Disease (CD) - Epidemiology Insights-2023- EU5
    Published: 01-Nov-2016        Price: US 1750 Onwards        Pages: 60
    DelveInsight's "Celiac Disease (CD) - Epidemiology Insights-2023- EU5" report provides an overview of the Celiac Disease and current scenario of the disease in the EU5 countries (France, Germany, Italy, Spain and UK)). It also includes historical and forecasted epidemiological data for the total prevalent and diagnosed prevalent cases of Celiac Disease in EU5 from 2013-2023. Celiac disease is a genetic autoimmune disease where the indigestion of gluten leads to damage in the small intesti......
  • Celiac Disease (CD) - Epidemiology Insights-2023- United States
    Published: 01-Nov-2016        Price: US 1750 Onwards        Pages: 60
    DelveInsight's "Celiac Disease (CD)- Market Insights, Epidemiology and Market Forecast-2023-United States" report provides an overview of the Celiac Disease and current scenario of the disease in the United States. It also includes historical and forecasted epidemiological data for the diagnosed prevalent cases of Celiac Disease in the United States from 2013-2023. Celiac disease is a genetic autoimmune disease where the indigestion of gluten leads to damage in the small intestine. The nu......
  • Diarrhea-Pipeline Insights, 2016
    Published: 01-Nov-2016        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, " Diarrhea-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Diarrhea. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, p......
  • Duodenal Ulcer-Pipeline Insights, 2016
    Published: 01-Nov-2016        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, " Duodenal Ulcer-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Duodenal Ulcer. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions,......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs